{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:25:45Z","timestamp":1725063945493},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"DOI":"10.7759\/cureus.68174","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T07:53:15Z","timestamp":1725004395000},"source":"Crossref","is-referenced-by-count":0,"title":["Treatment and Characteristics of Pachychoroid Neovasculopathy Accompanying Recalcitrant Intraretinal Cysts"],"prefix":"10.7759","author":[{"given":"Moon Young","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"Cheung CM","year":"2019","unstructured":"Cheung CM, Lee WK, Koizumi H, Dansingani K, Lai TY, Freund KB. Pachychoroid disease. Eye (Lond). 2019, 33:14-33. 10.1038\/s41433-018-0158-4","journal-title":"Eye (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001907","article-title":"Peripapillary pachychoroid syndrome","volume":"38","author":"Phasukkijwatana N","year":"2018","unstructured":"Phasukkijwatana N, Freund KB, Dolz-Marco R, et al.. Peripapillary pachychoroid syndrome. Retina. 2018, 38:1652-67. 10.1097\/IAE.0000000000001907","journal-title":"Retina"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003057","article-title":"The ambiguity of pachychoroid","volume":"41","author":"Spaide RF","year":"2021","unstructured":"Spaide RF. The ambiguity of pachychoroid. Retina. 2021, 41:231-7. 10.1097\/IAE.0000000000003057","journal-title":"Retina"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05450-3","article-title":"Pachychoroid disease spectrum: review article","volume":"260","author":"Mazzeo TJ","year":"2022","unstructured":"Mazzeo TJ, Leber HM, da Silva AG, et al.. Pachychoroid disease spectrum: review article. Graefes Arch Clin Exp Ophthalmol. 2022, 260:723-35. 10.1007\/s00417-021-05450-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-019-04388-x","article-title":"Retinoschisis in eyes with pachychoroid and retinal pigment epithelial atrophy","volume":"257","author":"Baek J","year":"2019","unstructured":"Baek J, Lee JH, Lee WK. Retinoschisis in eyes with pachychoroid and retinal pigment epithelial atrophy. Graefes Arch Clin Exp Ophthalmol. 2019, 257:1863-71. 10.1007\/s00417-019-04388-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314625","article-title":"Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy","volume":"104","author":"Romdhane K","year":"2020","unstructured":"Romdhane K, Zola M, Matet A, Daruich A, Elalouf M, Behar-Cohen F, Mantel I. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy. Br J Ophthalmol. 2020, 104:910-6. 10.1136\/bjophthalmol-2019-314625","journal-title":"Br J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38504-y","article-title":"Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy","volume":"9","author":"Jung BJ","year":"2019","unstructured":"Jung BJ, Kim JY, Lee JH, Baek J, Lee K, Lee WK. Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy. Sci Rep. 2019, 9:2055. 10.1038\/s41598-019-38504-y","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002188","article-title":"Choroidal morphology in eyes with peripapillary polypoidal choroidal vasculopathy","volume":"39","author":"Baek J","year":"2019","unstructured":"Baek J, Dansingani KK, Lee JH, Lee WK, Freund KB. Choroidal morphology in eyes with peripapillary polypoidal choroidal vasculopathy. Retina. 2019, 39:1571-9. 10.1097\/IAE.0000000000002188","journal-title":"Retina"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/15569527.2022.2068150","article-title":"Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy","volume":"41","author":"Karasu B","year":"2022","unstructured":"Karasu B, Akbas YB, Kaskal M, Aykut A, Celebi AR. Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy. Cutan Ocul Toxicol. 2022, 41:145-54. 10.1080\/15569527.2022.2068150","journal-title":"Cutan Ocul Toxicol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65370-w","article-title":"Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept","volume":"10","author":"Schworm B","year":"2020","unstructured":"Schworm B, Luft N, Keidel LF, Herold TR, Wolf A, Priglinger SG, Siedlecki J. Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept. Sci Rep. 2020, 10:8439. 10.1038\/s41598-020-65370-w","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.039","article-title":"Subfoveal choroidal thickness during aflibercept therapy for neovascular age-related macular degeneration: twelve-month results","volume":"123","author":"Koizumi H","year":"2016","unstructured":"Koizumi H, Kano M, Yamamoto A, et al.. Subfoveal choroidal thickness during aflibercept therapy for neovascular age-related macular degeneration: twelve-month results. Ophthalmology. 2016, 123:617-24. 10.1016\/j.ophtha.2015.10.039","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14773","article-title":"The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow","volume":"99","author":"Liu Y","year":"2021","unstructured":"Liu Y, Wang L, Xu Y, Pang Z, Mu G. The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow. Acta Ophthalmol. 2021, 99:730-8. 10.1111\/aos.14773","journal-title":"Acta Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107850","article-title":"Daily axial length and choroidal thickness variations in young adults: Associations with light exposure and longitudinal axial length and choroid changes","volume":"189","author":"Ulaganathan S","year":"2019","unstructured":"Ulaganathan S, Read SA, Collins MJ, Vincent SJ. Daily axial length and choroidal thickness variations in young adults: Associations with light exposure and longitudinal axial length and choroid changes. Exp Eye Res. 2019, 189:107850. 10.1016\/j.exer.2019.107850","journal-title":"Exp Eye Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-019-04524-7","article-title":"Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography","volume":"258","author":"Yang J","year":"2020","unstructured":"Yang J, Wang E, Yuan M, Chen Y. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2020, 258:241-7. 10.1007\/s00417-019-04524-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.12.010","article-title":"Age-related choroidal atrophy","volume":"147","author":"Spaide RF","year":"2009","unstructured":"Spaide RF. Age-related choroidal atrophy. Am J Ophthalmol. 2009, 147:801-10. 10.1016\/j.ajo.2008.12.010","journal-title":"Am J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3928\/15428877-20100303-05","article-title":"Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors","volume":"41","author":"Ehlers JP","year":"2010","unstructured":"Ehlers JP, Spirn MJ, Shah CP, Fenton GL, Baker PS, Regillo CD, Ho AC. Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors. Ophthalmic Surg Lasers Imaging. 2010, 41:182-9. 10.3928\/15428877-20100303-05","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2014.101","article-title":"Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results","volume":"28","author":"Grewal DS","year":"2014","unstructured":"Grewal DS, Gill MK, Sarezky D, Lyon AT, Mirza RG. Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results. Eye (Lond). 2014, 28:895-9. 10.1038\/eye.2014.101","journal-title":"Eye (Lond)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-012-1968-x","article-title":"External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy","volume":"250","author":"Chhablani JK","year":"2012","unstructured":"Chhablani JK, Kim JS, Cheng L, Kozak I, Freeman W. External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2012, 250:1415-20. 10.1007\/s00417-012-1968-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.02.019","article-title":"Retinal pseudocysts in age-related geographic atrophy","volume":"150","author":"Cohen SY","year":"2010","unstructured":"Cohen SY, Dubois L, Nghiem-Buffet S, et al.. Retinal pseudocysts in age-related geographic atrophy. Am J Ophthalmol. 2010, 150:211-217.e1. 10.1016\/j.ajo.2010.02.019","journal-title":"Am J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200302000-00001","article-title":"Cystoid macular degeneration in chronic central serous chorioretinopathy","volume":"23","author":"Iida T","year":"2003","unstructured":"Iida T, Yannuzzi LA, Spaide RF, Borodoker N, Carvalho CA, Negrao S. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina. 2003, 23:1-7; quiz 137-8. 10.1097\/00006982-200302000-00001","journal-title":"Retina"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/288958-treatment-and-characteristics-of-pachychoroid-neovasculopathy-accompanying-recalcitrant-intraretinal-cysts","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T07:53:19Z","timestamp":1725004399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/288958-treatment-and-characteristics-of-pachychoroid-neovasculopathy-accompanying-recalcitrant-intraretinal-cysts"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.68174","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}